Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “THE UNITED STATES OF AMERICA, as represented by th”

2,147 pharma patents match "THE UNITED STATES OF AMERICA, as represented by th" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,147
Index total 30,257
Page 32 / 90

Quick answer

This filtered view shows 2,147 pharmaceutical patents matching "THE UNITED STATES OF AMERICA, as represented by th" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,147 results for “THE UNITED STATES OF AMERICA, as represented by th” · 30,257 patents in full index Clear search

  1. US 9937191

    Inhibition of HIV infection through chemoprophylaxis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 10, 2018 · Expires Apr 5, 2038

    granted

  2. US 9937196

    Genomic sequence of avian paramyxovirus type 2 and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 10, 2018 · Expires Apr 5, 2038

    granted

  3. US 9937217

    Method of inhibiting ABCG2 and related treatments

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 10, 2018 · Expires Apr 5, 2038

    granted

  4. US 9931377

    Cell expressing complexes of IL-15 and IL-15Ralpha

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 3, 2018 · Expires Mar 29, 2038

    granted

  5. US 9931393

    Immunogenic JC polyomavirus compositions and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 3, 2018 · Expires Mar 29, 2038

    granted

  6. US 9932406

    Human monoclonal antibodies specific for glypican-3 and use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 3, 2018 · Expires Mar 29, 2038

    granted

  7. US 9920296

    Paenibacillus alvei strain TS-15 and its use in controlling pathogenic organisms on crops

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVIC · Granted Mar 20, 2018 · Expires Mar 15, 2038

    granted

  8. US 9919058

    Polyketal particles including a CpG oligodeoxynucleotide for the treatment of lung cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 20, 2018 · Expires Mar 15, 2038

    granted

  9. US 9908841

    Preparation of (R,R)-fenoterol and (R,R)- or (R,S)-fenoterol analogues and their use in treating congestive heart failure

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 6, 2018 · Expires Mar 1, 2038

    granted

  10. US 9902734

    Nicotinic acetylcholine receptor agonists

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 27, 2018 · Expires Feb 22, 2038

    granted

  11. US 9896509

    Use of antagonists of the interaction between HIV GP120 and α4β7 integrin

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 20, 2018 · Expires Feb 15, 2038

    granted

  12. US 9889115

    Fitness assay and associated methods

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted

  13. US 9890369

    Cytolethal distending toxin subunit B conjugated or fused to Bacillus anthracis toxin lethal factor

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted

  14. US 9884104

    Live attenuated virus vaccines for la crosse virus and other bunyaviridae

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 6, 2018 · Expires Feb 1, 2038

    granted

  15. US 9879065

    T cell receptors recognizing MHC class II-restricted MAGE-A3

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 30, 2018 · Expires Jan 25, 2038

    granted

  16. US 9879231

    Recombinant modified vaccinia ankara (MVA) vaccinia virus containing restructured insertion sites

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 30, 2018 · Expires Jan 25, 2038

    granted

  17. US 9873702

    Heterocyclic compounds as biogenic amine transport modulators

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 23, 2018 · Expires Jan 18, 2038

    granted

  18. US 9867830

    Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic pain

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Jan 16, 2018 · Expires Jan 11, 2038

    granted

  19. US 9868769

    Mutated Salmonella enteriaca

    The United States of America, as represented by the Secretary of Agriculture · Granted Jan 16, 2018 · Expires Jan 11, 2038

    granted

  20. US 9868774

    Anti-CD22 chimeric antigen receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 16, 2018 · Expires Jan 11, 2038

    granted

  21. US 9868943

    Enhanced staphylolytic activity of the Staphylococcus aureus bacteriophage vB—SauS-philPLA88 virion-associated peptidoglycan hydrolase HydH5: fusions, deletions and synergy with LysH5

    The United States of America, as represented by the Secretary of Agriculture · Granted Jan 16, 2018 · Expires Jan 11, 2038

    granted

  22. US 9868954

    Reduction of TGFβ signaling in myeloid cells in the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 16, 2018 · Expires Jan 11, 2038

    granted

  23. US 9862679

    Potent and selective inhibitors of monoamine transporters; method of making; and use thereof

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Jan 9, 2018 · Expires Jan 4, 2038

    granted

  24. US 9855330

    Granulysin in immunotherapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.